BSE - Delayed Quote INR
Unjha Formulations Limited (UNJHAFOR.BO)
24.13
-0.78
(-3.13%)
At close: April 25 at 3:12:33 PM GMT+5:30
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Krutiben Mayankkumar Patel | MD, Compliance Officer & Director | 1.24M | -- | 1963 |
| Mr. Ganpatbhai Bhikhabhai Prajapati | Chief Financial Officer | -- | -- | -- |
| Mr. Jigar P. Ray | Company Secretary | -- | -- | -- |
Unjha Formulations Limited
Khali Char Rasta
State Highway
Sidhpur, 384151
India
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 17
Description
Unjha Formulations Limited engages in the manufacture and sale of ayurvedic products in India. It offers sat-isabgol and isabgo husk formulation in elaichi flavor under the Anchor name; and isabgol powder in orange flavor under the Fibron and Fibron SF names. The company also exports its products. Unjha Formulations Limited was incorporated in 1994 and is based in Sidhpur, India.
Corporate Governance
Unjha Formulations Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 16, 2025 at 8:00 AM UTC
Unjha Formulations Limited Earnings Date
Recent Events
Recent Events Information Not Available